JOIN US FOR THE 2025 EDUCATION & SUPPORT SUMMIT!

Lisa Hall joins ZERO as our Director of Health Equity, Community Organizing & Engagement, bringing over two decades of healthcare leadership experience focused on addressing health disparities in chronic diseases. Her expertise in risk management, business development, and implementing evidence-based interventions positions her perfectly to lead ZERO's initiatives in reducing racial disparities in prostate cancer care.

In her most recent role as Senior Director of Business Development with Native American Connections, Lisa worked to improve the lives of Native American individuals and families through culturally appropriate behavioral health and community development services. Her extensive career spans work with regional and national health insurance organizations, clinical providers, and the pharmaceutical industry, consistently focusing on addressing health disparities within at-risk populations.

Dr. Leanne Woods-Burnham is an Assistant Professor in the Department of Surgery at Morehouse School of Medicine in Atlanta, GA. Her team focuses on prostate cancer health disparities. She is a translational scientist, and her team evaluates genetic and molecular drivers of aggressive tumor biology associated with genetic ancestry. Dr. Burnham has fostered several national multidisciplinary collaborations with clinicians and pharma to conduct translational research studies and clinical trials for patients. She co-directs the Prostate Cancer Precision Prevention Program (PCP3) which leverages community partnerships to provide health education and free PSA tests to at-risk men in the greater Atlanta area. Dr. Burnham has been recognized by Cell’s #FacesofCell Twitter campaign to increase visibility of talented Black scientists, as well as The Cancer Health 25: Black Lives Matter, as a “remarkable individual breaking down racial barriers to better cancer care.” In 2025, she has been awarded “Innovator of the Year—Men’s Health” by the Atlanta Business Chronicle and “1,000 Inspiring Black Scientists in America” by Cell MENTOR.

Victor LaGroon, recently worked as the Head Consultant of Global Health Equity Strategy at Assurance Health Data. Before assuming his current position, Victor served as the inaugural Chief Diversity Officer at the Office of the Secretary, US Department of Veterans Affairs, the largest healthcare system in the country. With a focus on influencing policy and advocating for the broader Veteran population, Victor brings nearly two decades of experience in academia and healthcare systems, dedicated to advancing health equity for at-risk and underserved communities.

Before joining the Biden Administration, Victor held the role of Director of Strategic Partnerships and Alliances for the Division of Health Equity at the Department of Population Sciences at City of Hope. In Chicago, Victor was the first appointee as the Director of the Mayor's Office of Veterans Affairs for the City of Chicago after several terms serving as the Chairman of the Advisory Council of Veterans Affairs for Mayor Rahm Emanuel and was an active member of the Mayor’s Commission for a Safer Chicago. Additionally, he contributed to statewide efforts as an appointee to the Illinois Joining Forces Foundation Board.

Victor's deep understanding of underserved populations, coupled with an extensive nationwide network of regional non-profit, for-profit, and governmental partners, uniquely equips him to develop effective and transformational programs with a lasting impact on underserved populations.

Victor attributes his commitment to serving people to his time with the 10th Mountain Division, U.S. Army, where he served as an Intelligence Analyst and was medically retired in 2006. A national speaker and advocate, Victor has testified before the 117th Congressional House Veterans Affairs Committee on issues such as access to care, Veterans benefits, transition, and employment strategies, focusing on those from at-risk and underrepresented communities. He previously chaired the Black Veteran Empowerment Council, advocating for policy changes to ensure equitable utilization of benefits for African American Service Members and Veterans.

Shonta transitioned back to the non-profit sector in 2014 by joining PAF. She leads the development and execution of strategic initiatives to expand PAF’s approach to achieve health equity through community and national level partnership engagement and mobilization. These initiatives are designed to link limited income communities to resources to abate financial, logistical and social access to care barriers. She brings to this role nearly 20 years of non-profit and public sector middle and senior level experience that spans public health, women’s health and behavioral health. Additionally, she serves as the Principal Investigator on record as part of DP13-1314 CDC’s National Networks to Reduce Cancer and Tobacco Related Disparities Cooperative Agreement. In this role, she administers the SelfMade Health Network a national network focused on reducing cancer and tobacco related disparities among populations with low socio-economic characteristics. Shonta enjoys mentoring young women, golf, and watching her sons play baseball.

In 2021, Eric Morrow was diagnosed at age 49 with very-high risk, locally metastatic prostate cancer. A husband and father with two teenage children at the time, Eric opted for an aggressive treatment program including robotic assisted radical prostatectomy, two years of androgen deprivation therapy (ADT, hormone therapy), and external beam radiation therapy. He completed ADT in October 2023 and remains optimistic about his long-term prognosis and future prostate cancer research and treatment developments.

Eric grew up in Santa Monica, CA, and attended Franklin Elementary School, Lincoln Jr. High School, and Santa Monica High School. He was a member of Troop 2 from 1982 through 1989, attaining the rank of Life Scout. After graduating from Samohi, Eric attended the United States

Air Force Academy, where he earned a Bachelor of Science degree in Political Science and was a member of the Falcons’ NCAA Division I cross country and track teams. Upon graduation from USAFA in 1993, Eric was commissioned a second lieutenant in the United States Air Force. He is also a graduate of the US Air Force Weapons School (Air Force “Top Gun” program) and holds a Master of Science degree in Defense Analysis from the Naval Postgraduate School and a Master

of Business Administration degree from the University of Maryland.

During his 20-year Air Force career, Eric held positions as a F-15C squadron intelligence officer, fighter wing intelligence weapons officer, training course commander, squadron director of operations, detachment commander, and squadron commander. He also qualified as a Cyber

Effects Operations Officer, Political-Military Affairs Strategist, and Special Operations Subspecialist. His combat experience includes over 1,500 days deployed to Saudi Arabia, Jordan, Turkey, Iraq, Afghanistan, and various undisclosed overseas locations. 

After retiring from the Air Force in 2013, Eric next spent ten years as a sales rep and Executive Vice President of Operations with a surgical implant distributorship before retiring again in 2023 to devote more time to family and prostate cancer advocacy efforts. Currently, Eric is a ZERO Prostate Cancer Champion, MENtor, and a member of ZERO’s Veterans Advisory Board. Additionally, he serves as a Programmatic Reviewer with the Congressionally Directed Medical Research Program’s Prostate Cancer Research Program, and also volunteers as a patient advocate with the Center for Prostate Disease Research at Walter Reed National Military Medical Center Bethesda. He currently works from home in Bowie, Maryland.

Dr. Leeman is an Assistant Professor of Radiation Oncology at Harvard Medical School and serves as the director of MRI guided and adaptive radiotherapy at the Dana-Farber Brigham Cancer Center in Boston, MA. He received his AB from Harvard College and is a graduate of the Physician Scientist Training Program at the University of Pittsburgh School of Medicine. He completed his internship and residency in radiation oncology at Memorial Sloan Kettering Cancer Center in New York, NY where he served as Chief Resident. His clinical expertise lies in the areas of MRI guided radiotherapy, adaptive radiotherapy and prostate cancer. His research focuses on the application of MR imaging technology and adaptive radiotherapy for the advancement of prostate cancer treatment to improve treatment outcomes by reducing side effects of treatment and improving disease control for patients at all stages of disease.

Nilay M. Gandhi, MD

Urologist | Potomac Urology

Dr. Nilay Gandhi grew up in Memphis, TN and has lived in Virginia since 2015. He trained at the prestigious Brady Urological Institute at Johns Hopkins Hospital, where he cultivated his skills with many pioneers in the field. He has published numerous articles in prestigious journals, written multiple book chapters, and presented at various regional and national medical conferences. He firmly believes that as a physician, he can also serve as the patient’s best advocate.

Neal Shore graduated from Duke University and Duke University Medical School. He completed his general surgery/urology residency at New York Hospital-Cornell Medical Center/Memorial Sloan Kettering Cancer Center. He serves as the Medical Director for the Carolina Urologic Research Center. Dr. Shore has conducted more than 400 clinical trials, focusing mainly on genitourinary oncology, and has authored more than 350 peer-reviewed publications and numerous book chapters. He serves on the Society for Immunotherapy of Cancer (SITC) Guidelines Committee for Bladder Cancer, as well as the boards of the Bladder Cancer

Advocacy Network, the APCCC Scientific Steering Committee, Maple Tree Cancer Alliance, and the Duke Global Health Institute. He is the Chair of both the Prostate Cancer Academy and the Bladder/Kidney Cancer Academy, and the co-chair of the annual AUA International Prostate Forum. He has served/serves on the editorial boards of Reviews in Urology, Urology Times, Chemotherapy Advisor, OncLive, PLOS ONE,

Urology Practice, JUOP, Everyday Urology Oncology and World Journal of Urology. He is the Editor-in-Chief of Reviews in Urology. He is a Fellow of the American College of Surgeons and a Certified Physician Investigator.

Dr. Jeffrey Albaugh is a board-certified Advanced Practice Urology Clinical Nurse Specialist, researcher, and author based in Chicago with over 30 years of experience caring for individuals with sexual dysfunction. He is also a Certified Sexuality Counselor. He hosts his own podcast "Dr. Jeff Talks about Sex & Intimacy on Tuesday evenings at 7PM. Dr. Albaugh has his own clinc at the Jesse Brown VA Medical Center, serving Veterans. Previously, he was the Director of Sexual Health at Endeavor/NorthShore University HealthSystem and held a similar role at Northwestern Memorial Hospital. His NIH-funded PhD research at the University of Illinois in Chicago focused on quality of life in men with sexual dysfunction following prostatectomy for prostate cancer. An internationally recognized expert and speaker, Dr. Albaugh has presented across the United States and in countries including Spain, Italy, Scotland, Ireland, New Zealand, and Australia. A prolific author, he has contributed numerous peer-reviewed articles, book chapters, and published his own books including "Reclaiming Sex & Intimacy after Prostate Cancer 2nd Edition".. His contributions have been recognized with multiple honors, including nursing excellence awards, SUNA President’s Awards, the Patient’s First Award from Northwestern, and the Edward C. Kaps Hope Award for his work with men facing prostate cancer. A trusted voice in the media, Dr. Albaugh has been featured on WGN News, CBS 2 Chicago, and in the Chicago Tribune, where he was highlighted in the “Ask the Expert” column.

Joseph D. Shirk, MD is the Chief of Urology and Director of the Clinical Procedures Center at the Greater Los Angeles VA Health System and Assistant Professor of Urology at the David Geffen School of Medicine at UCLA.Dr. Shirk earned his medical degree from the Medical College of Wisconsin. He completed his intern year at Boston Medical Center and subsequently completed his urology residency at the University of California, Los Angeles (UCLA) and urologic oncology fellowship training at UCLA’s Institute of Urologic Oncology (IUO) and David Geffen School of Medicine.Dr. Shirk performs complex urologic oncology operations, including robotic prostatectomy, cystectomy, partial nephrectomy, retroperitoneal lymph node dissection, and tumor thrombectomy. His primary research interests include the development and use of advanced, innovative imaging techniques.  He is the cofounder of Ceevra, Inc, which is a company that has developed an AI driven platform to create 3D, digital images that surgeons use to guide their operations.

Stacey A. Kenfield, ScD received her Bachelor of Science from UCLA in Physiological Science, followed by a Master of Science in Epidemiology, a Doctor of Science in Epidemiology, and a post-doctoral fellowship, all completed at the Harvard T.H. Chan School of Public Health. She continues to lead the Harvard-based Health Professionals Follow-up Study (HPFS) prostate cancer clinical follow-up of more than 7,500 men with prostate cancer since assuming this role in 2005. These data are used to identify factors that may improve prognosis and quality of life. She has worked in cancer epidemiology for the past 10 years and received a Prostate Cancer Foundation Young Investigator Award in 2012. She was recently appointed as the Helen Diller Family Chair in Population Science for Urologic Cancer in 2016.

Greta Macaire, MA, RD, CSO

Oncology Dietitian Nutritionist

University of California, San Francisco Helen Diller Family Comprehensive Cancer Center

Greta is an Oncology Dietitian Nutritionist at University of California, San Francisco Helen Diller Family Comprehensive Cancer Center.

Greta has specialized in oncology nutrition for over twenty years and has been involved in several prostate cancer diet and lifestyle studies.  She offers patients nutrition guidelines for specific cancers, supportive nutrition during treatment, and optimizing healthy eating patterns to maximize wellness and quality of life. 

Stacy Loeb, MD

Urologist | New York University Langone Health

Dr. Stacy Loeb is a Professor of Urology and Population Health at New York University (NYU) Langone Health and the Manhattan Veterans Affairs Medical Center, specializing in prostate cancer. Dr. Loeb completed her urology residency training at Johns Hopkins and subsequently completed a Masters of Science in Comparative Effectiveness Research at New York University. She currently has grants from the Prostate Cancer Foundation, Department of Defense, Centers for Disease Control and National Cancer Institute.

Dr. Loeb has published more than 450 peer-reviewed articles and 10 book chapters, primarily on prostate cancer, men's health, lifestyle medicine and social media. She is on the Editorial Board for the Journal of Clinical Oncology, European Urology, Nature Reviews in Urology and Urology Times. 

Dr. Loeb is an active participant on social media and hosts the Men’s Health Show on Sirius XM 110 US/Canadian satellite radio on Wednesdays from 6-8pm EST. She frequently gives international lectures and courses on prostate cancer, men's health, lifestyle medicine and social media.

Dr. Elisabeth Heath is a nationally and internationally recognized expert in genitourinary oncology, serving as the Chair of the Department of Oncology at the Mayo Clinic in Rochester, MN. She specializes in clinical and translational research, focusing on early-phase and genitourinary clinical trials and addressing important health disparities. Her expertise covers a range of genitourinary cancers, including prostate, kidney, and bladder cancer.

 

In addition to her clinical work, Dr. Heath has led large-scale, multi-institutional, peer-reviewed research initiatives aimed at fostering collaboration across medical disciplines. Her goal is to integrate research and clinical practice, translating scientific discoveries into real-world treatments.

 

Dr. Heath is also committed to improving patient access to care and their experience during treatment. She emphasizes collaboration within multidisciplinary teams to achieve holistic, effective patient outcomes. Her leadership and innovative approaches have advanced the understanding and treatment of genitourinary cancers while shaping cancer care practices both nationally and internationally. Through her work, Dr. Heath continues to contribute significantly to the oncology community, with a focus on patient-centered care and health equity.

I am a retired engineer and manager, having retired in 2012 after 45 years in electronics, microelectronics and satellite systems.  The last 5 years of my retirement has been a roller coaster ride with many ups and downs.  ZERO has been instrumental in keeping me mostly in the ups.

A ZERO Prostate Cancer advocate and a prostate cancer warrior who was diagnosed in 2020 with Stage 4 cancer, Gleason 9 and mets to bones and outside my prostate and bladder. To say this was "unexpected and a big shock" is an understatement.  Over the last 5 years I’ve gone through many treatments including ADT and extensive radiation sessions. When my cancer became resistant to my treatments in late 2024, I had one chemo infusion and then started Pluvicto treatments. I was fortunate to be selected for a clinical trial at UCLA for Pluvicto, Flexible MRT (control group). I have completed 3 of 6 infusions. So far, my results have been excellent with SpectCT scans showing >90% reduction in tumor size and no new tumors. That’s my path so far on my journey with this unrelenting disease.

Dr. Morgans is an Associate Professor of Medicine at Harvard Medical School, a Genitourinary Medical Oncologist and the Director of the Survivorship Program at Dana-Farber Cancer Institute. As a clinician and investigator, she has expertise in clinical trials and patient-reported outcome measures, as well as incorporating patient preferences and beliefs into clinical decision making. Her research has investigated complications of systemic therapy for prostate cancer survivors, including the study of skeletal, cardiovascular, diabetic, and cognitive complications, and her work has been funded by grants from the Prostate Cancer Foundation , the National Comprehensive Cancer Network, and the Department of Defense. She leads multiple therapeutic and quality of life focused clinical trials for prostate cancer patients, and has participated in the advanced and localized prostate cancer treatment guidelines committees of the American Urologic Association, and the cardio-oncology committee of American Heart Association.  

Dr. Elisabeth Heath is a nationally and internationally recognized expert in genitourinary oncology, serving as the Chair of the Department of Oncology at the Mayo Clinic in Rochester, MN. She specializes in clinical and translational research, focusing on early-phase and genitourinary clinical trials and addressing important health disparities. Her expertise covers a range of genitourinary cancers, including prostate, kidney, and bladder cancer.

 

In addition to her clinical work, Dr. Heath has led large-scale, multi-institutional, peer-reviewed research initiatives aimed at fostering collaboration across medical disciplines. Her goal is to integrate research and clinical practice, translating scientific discoveries into real-world treatments.

 

Dr. Heath is also committed to improving patient access to care and their experience during treatment. She emphasizes collaboration within multidisciplinary teams to achieve holistic, effective patient outcomes. Her leadership and innovative approaches have advanced the understanding and treatment of genitourinary cancers while shaping cancer care practices both nationally and internationally. Through her work, Dr. Heath continues to contribute significantly to the oncology community, with a focus on patient-centered care and health equity.

Charles J. Ryan, MD, is an internationally recognized genitourinary (GU) oncologist with expertise in the biology and treatment of and supportive care of all men with prostate cancer, seeing patients at Memorial Sloan Kettering Cancer Center in New York. Dr. Ryan earned a BA in Philosophy, magna cum laude, from Marquette University and graduated from the University of Wisconsin Medical School. He trained at the University of Wisconsin Hospital and Clinics, and at Memorial Sloan Kettering Cancer Center. 

As faculty at the University of California-San Francisco, he was named the Thomas Perkins Distinguished Professor in Cancer Research. He has received research funding from the National Institutes of Health, the Department of Defense Prostate Cancer Research Program, and the Prostate Cancer Foundation. Ryan has published over 200 articles and chapters in the world’s leading medical journals and is the author of the book The Virility Paradox: The Vast Influence of Testosterone on Our Bodies, Minds, and the World We Live In. Dr. Ryan is a past Chair of the National Cancer Institute’s GU Steering Committee’s Prostate Cancer Task Force. 

From 2018 to 2021 he served as Director of the Division of Hematology, Oncology and Transplantation at the University of Minnesota, where he was the BJ Kennedy Chair in Clinical Oncology. From 2021 to 2024 Ryan served as the CEO of the Prostate Cancer Foundation. He serves on the Scientific Oversight Committee of the Prostate Cancer Clinical Trials Consortium and is a member of the Advanced Prostate Cancer Consensus Conference. Dr. Ryan is a member of ZERO's Medical Advisory Board.

Brian Bragg serves as ZERO Prostate Cancer's Chief Mission Officer. He is a seasoned healthcare leader with over 20 years of progressive leadership experience in public health and health promotion. He has specific expertise in community and population health and health systems integration. 

As Chief Mission Officer, Brian is leading a comprehensive approach, working both in-community and virtually to accelerate and expand mission delivery. One of his top priorities is to build capabilities in interventions, outreach, and health programs across the prostate cancer continuum, piloted in underserved communities to drive nationwide health equity impacts. He’s also driving volunteer efforts and collaborative partnerships with organizations on the ground to best serve those impacted by prostate cancer at the local level. 

With decades of extensive leadership experience, Brian has dedicated his career to ensuring communities have access to quality health care and building programs that promote health equity. For more than 24 years, he’s served in leadership positions overseeing health initiatives at Access Community Health Network (ACCESS) in Chicago, one of the largest Federally Qualified Health Centers (FQHCs) in the United States. Most recently, as the Vice President of Health Equity, Brian advanced critical programs in primary care, behavioral health, and infectious disease with a focus on addressing health disparities.

Ernie Johnson, Jr. is one of sports’ most respected and loved personalities. He is an eight-time Sports Emmy Award-winning sportscaster for Warner Bros. Discovery’s TNT Sports. He is the host of TNT’s NBA coverage on the multi-Emmy Award-winning “Inside the NBA” studio show with analysts Charles Barkley, Kenny Smith, and Shaquille O’Neal. He is also co-host of The Steam Room podcast and a host for Turner Sports and CBS's NCAA Division I Men's Basketball Championship coverage as well as play-by-play announcer for TBS’ exclusive coverage of Major League Baseball and the PGA Championship. Previously, Johnson has covered the National Football League, the British Open, Wimbledon and the Olympics. In addition to his professional accolades and lifetime achievement awards, Ernie has earned honors recognizing his incredible actions off- camera, including the first-ever John Wooden Keys to Life Award and a Musial Award, both of which salute characteristics such as integrity, faith, and good sportsmanship. He is also a Georgia Sports Hall of Fame inductee. In December 2023, Ernie was inducted into the Sports Broadcasting Hall of Fame and will be inducted into the Wisconsin Athletic Hall of Fame in July 2025. 

Maybe more impressive than his professional fame and recognition is Ernie's innate ability to connect with people on a human level. While Johnson has experienced a myriad of professional successes, his biggest passion lies with one thing – his family. Driven by appreciating the ”Blackberry Moments” in life, a term Johnson coined from a memory of playing baseball as a kid, he is reminded to embrace the unexpected, unscripted moments that take place away from offices, conference calls and e-mails. There have been sweet, unscripted Blackberry Moments for Johnson – memories with his wife and children and seemingly mundane moments that have a lasting effect. There have also been unscripted Blackberry Moments with some thorns –the loss of loved family members and his personal battle with cancer. But throughout all of them, Johnson is thankful for what his Blackberry Moments have taught him. In his book, UNSCRIPTED: THE UNPREDICTABLE MOMENTSTHAT MAKE LIFE EXTRAORDINARY, Ernie takes readers behind the scenes of those very moments. “We’re all so focused on sticking to the script from one day to the next, one meeting to the next, one sales call to the next, that we blow right by the unscripted moments that can profoundly impact not just our lives but also the lives of those with whom we share the planet, the workplace, or a home, ”Johnson said. “If there’s one thing life has taught me, it’s not to fear the unscripted but to embrace it.”

Brian Bragg serves as ZERO Prostate Cancer's Chief Mission Officer. He is a seasoned healthcare leader with over 20 years of progressive leadership experience in public health and health promotion. He has specific expertise in community and population health and health systems integration. 

As Chief Mission Officer, Brian is leading a comprehensive approach, working both in-community and virtually to accelerate and expand mission delivery. One of his top priorities is to build capabilities in interventions, outreach, and health programs across the prostate cancer continuum, piloted in underserved communities to drive nationwide health equity impacts. He’s also driving volunteer efforts and collaborative partnerships with organizations on the ground to best serve those impacted by prostate cancer at the local level. 

With decades of extensive leadership experience, Brian has dedicated his career to ensuring communities have access to quality health care and building programs that promote health equity. For more than 24 years, he’s served in leadership positions overseeing health initiatives at Access Community Health Network (ACCESS) in Chicago, one of the largest Federally Qualified Health Centers (FQHCs) in the United States. Most recently, as the Vice President of Health Equity, Brian advanced critical programs in primary care, behavioral health, and infectious disease with a focus on addressing health disparities.

Courtney Bugler is a trailblazing nonprofit executive with extensive experience in leading national health charities to advance program development, organizational infrastructure, fundraising, and advocacy. As the CEO and President of ZERO Prostate Cancer, she brings a strong track record of success and a deep commitment to advancing the organization's mission. 

Prior to her appointment at ZERO Prostate Cancer, Courtney served as the Chief Development and Marketing Officer at the Piedmont Park Conservancy. Courtney played a pivotal role in elevating the organization's profile and expanding its philanthropic efforts despite the challenges posed by the global pandemic. Throughout her career, Courtney has been passionate about driving systemic progress in public health to save lives. Previously, she spearheaded substantial organizational change and growth as the National Director of the Race for the Cure / MORE THAN PINK Walk Series at Susan G. Komen, leading a nationwide affiliated staff of 200 to successfully transform a top-ten National Peer-to-Peer Walk Series. While at Komen, she led the rollout of a new brand and restructured a support team of fundraisers to drive a yearly revenue budget of nearly $50 million. She has also held notable positions at JDRF International and the Young Survival Coalition, where she made significant contributions to fundraising, program development, and organizational expansion. 

Courtney is a highly trained consumer advocate with more than fifteen years of expertise in cancer, healthy equity, chronic disease management, and public health communications. She is certified and trained in patient navigation, cancer survivor support modules and facilitation, as well as grant review and evaluation. She has lobbied on Capitol Hill for more than a billion dollars in funding toward the Department of Defense Congressionally Directed Medical Research Program and has served as a consumer advocate research grant reviewer for that same program. 

Courtney has researched, written, and developed some of the most successful programs and health communication tools for young women with breast cancer and at-risk populations through her work with the Young Survival Coalition and the state of Georgia. Courtney is an outstanding presenter and dynamic public speaker, addressing hundreds of thousands of people live and through media on disparities in cancer care and access, cancer survivorship, and psychosocial support needs. She holds a Bachelor's degree in Communications from Northwestern University and is a Certified Fundraising Executive®.

As a caregiver to her father, who currently lives with prostate cancer, and a seventeen-year cancer survivor herself, Courtney is honored to be at the forefront of the fight against prostate cancer. Courtney lives in Atlanta, GA, with her son and two rescue dogs.

Leslie J. Waltke, PT, DPT is a physical therapist with a clinical mastery in cancer rehabilitation and a provider of world class cancer rehabilitation program development consulting and continuing education. Since earning her degree in Physical Therapy from the University of Wisconsin in 1988, Dr. Waltke has dedicated most of her career solely to treating the cardiopulmonary, musculoskeletal, integumentary and functional needs of persons during and after treatment for cancer. Over the past decades Dr. Waltke has cared for thousands of people with cancer and has a following of beloved patients. She is respected nationally and internationally as an oncology physical therapist, cancer rehabilitation key opinion leader,

author, educator and consultant. Since 2005 Dr. Waltke has been the Cancer Rehabilitation Coordinator for Aurora Health Care, one of

the United States’ largest CoC and NAPBC accredited cancer programs and proud holder of the rare Commission on Cancer “Outstanding Achievement Award.” Her role, in addition to treating patients with cancer, includes cancer rehabilitation program development, program integration, education and training, and best practice and clinical standards development.

A gifted and impassioned speaker, Dr. Waltke teaches and lectures throughout the world with the Waltke Cancer Rehabilitation Academy to rehab professionals, universities, medical and oncology providers, cancer organizations as well as cancer patients and survivors. She spoke at the 2014 China Cancer Congress and the 2015 and 2017 World Cancer Congresses. In 2022 she worked with the World Health Organization to standardize oncologic rehabilitation interventions. Dr. Waltke holds a certificate in Online Education from the University of Wisconsin, is a former Board Member of the Oncology Section of the American Physical Therapy Association, an APTA Credentialed Clinical Instructor, on the Specialization Academy of Content Experts and a is a founding and current board member of ABCD, Inc. (After Breast Cancer Diagnosis). Honors include the “2014 Article of the Year Award” from the Journal of Patient-Centered Research and Reviews, the 2015 Academic Excellence

and Leadership Award from Rosalind Franklin University of Medicine and Science, and the 2015 Physical Medicine and Rehabilitation Education Recognition scholarship. Dr. Waltke is a member of ASCO and ACE, the Association of Cancer Executives. Dr. Waltke’s drive and vision to make the world better for people facing illness led her to OneVillage, where she is honored to serve as Chief Wellness Officer.

Erica graduated with her master’s degree in Occupational Therapy from Concordia University Wisconsin in 2002. Erica works full time in hospital-based outpatient rehabilitation at Aurora Sinai Medical Center, part of Aurora Health Care, in downtown Milwaukee, Wisconsin. Erica specializes in male, female, and pediatric evaluation and treatment of the pelvic floor and related bladder, bowel, and sexual health issues. Erica is Board Certified in Biofeedback for Pelvic Muscle Dysfunction (BCB-PMD) through the Biofeedback Certification International Alliance and is a Board

Certified Pelvic Rehabilitation Practitioner (PRPC) through Herman and Wallace Pelvic Rehabilitation Institute. Erica is a faculty member at Herman and Wallace Pelvic Rehabilitation Institute and has authored the 2-day virtual course, Parkinson Disease and Pelvic Rehabilitation, developed for pelvic health clinicians to further their knowledge for best practice for this specialized population. Erica is certified in LSVT (Lee Silverman) BIG, delivering specialty Parkinson disease rehabilitative care

utilizing this intensive, amplitude, neuroplasticity, researched based exercise and functional protocol. Erica is an LSVT Global faculty member instructing the LSVT BIG training and certification course nationally and internationally, online webinars, and presenting yearly at the American Occupational Therapy Association (AOTA) national conference.  Erica partners with the Wisconsin Parkinson Association (WPA) as a support group and annual symposium speaker and authors publications in the

Wisconsin Parkinson Magazine.

Monica Fawzy Bryant is a cancer rights attorney and the co-founder and Chief Operating Officer for Triage Cancer. Monica has dedicated her career to improving access to and availability of quality information on the practical, insurance, financial, and legal issues surrounding serious medical conditions, like cancer. She has provided more than one thousand educational seminars, written articles and co-authored a book published by the American Bar Association called Cancer Rights Law: An Interdisciplinary Approach, as well as appeared on television and radio discussing healthcare related legal issues.  Previously, Monica worked as Legislative Counsel for U.S. Congresswoman Linda T. Sanchez and Law Clerk for U.S. Senator Dianne Feinstein.

Pheobe Tsao, M.D., is a medical oncologist specializing in the treatment of advanced prostate cancer at the Ann Arbor Veterans Affairs Hospital. She was part of the 2023-34 Research Incubator Program cohort. Her Incubator project used Michigan Medicine clinical data to examine the impact of androgen receptor signaling inhibitors (ARSI’s) on depression and anxiety in men with prostate cancer. As the number of men taking ARSI’s for early-stage prostate cancer is expected to increase, this project seeks to contribute evidence of the potential effects on depression and anxiety so that patients can make informed treatment decisions.

Dr. Tosoian specializes in the early diagnosis and management of urologic cancers. In addition to his role as a clinician and surgeon, he is a recognized leader in clinical and translational prostate cancer research. His early research demonstrated the safety of monitoring lower-risk prostate cancers on active surveillance, allowing appropriately selected patients to delay or avoid treatment altogether. His ongoing research has led to the development of new, non-invasive tools to guide cancer diagnosis and management. Dr. Tosoian leads the Prostate Cancer Risk Clinic, a clinical program for informed early screening in patients with a strong family history or known genetic mutation associated with prostate cancer. 

Dr. Hafron is the Chief Medical Officer and Medical Director of Clinical Research at the Michigan Institute of Urology (MIU). Dr. Hafron is a Professor of Urology at the William Beaumont School of Medicine, Oakland University, Royal Oak, Michigan. He is experienced in all areas of adult urology, specializing in prostate, kidney, and bladder cancer.

Dr. Hafron received his Bachelor of Science degree from the University of Michigan and his Doctor of Medicine from Loyola University Chicago-Stritch School of Medicine. Dr. Hafron completed his General Surgery and Urology Residency at Albert Einstein College of Medicine, Montefiore Medical Center in New York City. He continued his training as a Fellow in Advanced Laparoscopic and Robotic Surgery at the Cleveland Clinic Foundation, Glickman Urological and Kidney Institute, Cleveland, Ohio.

Dr. Hafron has published numerous peer-reviewed journal articles on topics related to his expertise and has presented his work at many national and international scientific meetings. He is the recipient of many clinical research awards. He is on the Editorial Board of the journal International Urology and Nephrology, Urologists in Cancer Care and Urology Times. He previously served on the Board of Directors of the United Physicians Organization and currently serves on the Board of Directors for LUGPA, Michigan Men’s Health Foundation and

FORCE-Facing Hereditary Cancer EMPOWERED. Dr. Hafron is board-certified in the specialty of Urology by the American Board of Urology.

Dustin Nowaskie, MD (they/them/theirs) Dr. Nowaskie is a queer, nonbinary psychiatrist. Their personal identification and civic commitment have cultivated into a passion to help LGBTQ+ communities. They are the Founder, President, and Chief Medical Officer of the national nonprofit LGBTQ+ health equity organization OutCare Health, which provides access to LGBTQ+ information, resources, programming, mentorship, education, training, research, and providers for millions across the world. A Summa Cum Laude and Phi Beta Kappa graduate of the University of Southern California and Gold Humanism Honor Scholar of the Indiana University School of Medicine, Dr. Nowaskie’s clinical and philanthropic work has led to several national accolades, presentations, and publications as well as diversity awards from the Jack Kent Cooke Foundation, American Medical Association, Tylenol Future Care Foundation, Gamma Mu Foundation, Association of LGBTQ+ Psychiatrists, World Professional Association for Transgender Health, and Out to Innovate. Their ultimate goal is to transform their might into a powerful unicorn of social and public health change for LGBTQ+ people.

Dr. Leanne Woods-Burnham is an Assistant Professor in the Department of Surgery at Morehouse School of Medicine in Atlanta, GA. Her team focuses on prostate cancer health disparities. She is a translational scientist, and her team evaluates genetic and molecular drivers of aggressive tumor biology associated with genetic ancestry. Dr. Burnham has fostered several national multidisciplinary collaborations with clinicians and pharma to conduct translational research studies and clinical trials for patients. She co-directs the Prostate Cancer Precision Prevention Program (PCP3) which leverages community partnerships to provide health education and free PSA tests to at-risk men in the greater Atlanta area. Dr. Burnham has been recognized by Cell’s #FacesofCell Twitter campaign to increase visibility of talented Black scientists, as well as The Cancer Health 25: Black Lives Matter, as a “remarkable individual breaking down racial barriers to better cancer care.” In 2025, she has been awarded “Innovator of the Year—Men’s Health” by the Atlanta Business Chronicle and “1,000 Inspiring Black Scientists in America” by Cell MENTOR.